(Q51470261)
Statements
Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. (English)
1 reference
C Schwarz
1 reference
W Mehnert
1 reference
1 March 1999
1 reference
16
1 reference
2
1 reference
205-213
1 reference